District Court Orders New Jersey Defendants to Stop Distributing Unapproved ‘Nano Silver’ Products Touted as COVID Treatment | OPA
A federal court permanently enjoined a New Jersey entity and its principals from distributing unapproved and misbranded drugs touted as a treatment for COVID-19. In...